Ultragenyx Pharmaceutical Inc header image

Ultragenyx Pharmaceutical Inc

RARE

Equity

ISIN null / Valor 22860122

NASDAQ (2026-04-21)

USD 24.10-3.83%

Ultragenyx Pharmaceutical Inc
UMushroom community rating:

3.20 10 votes No rating yet

NegativeNeutralPositive

About company

Ultragenyx Pharmaceutical Inc is a biopharmaceutical company that focuses on developing and commercializing innovative treatments for rare and ultra-rare genetic diseases. The company's portfolio includes products such as DOJOLVI® for long-chain fatty acid oxidation disorders and CRYSVITA® for X-linked hypophosphatemia and tumor-induced osteomalacia. Ultragenyx is dedicated to providing patients with life-changing therapies that address unmet medical needs in the rare disease community.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-31.9%1Y

-42.9%3Y

-77.9%5Y

Performance

81.1%1Y

59.1%3Y

56.8%5Y

Volatility

2329 M

Market cap (USD)

1,387,164

Daily traded volume (Shares)

43.045 / 41.53

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

3.20

10 votes

Performance:

3.50

Innovation:

3.60

Society:

3.40

Nature:

3.10

oliver baigel

United Kingdom, 09 Nov 2025

a very low performing stock with a high level of risk

Yam Yi Pan

United Kingdom, 08 Nov 2025

1

Misha Batvinov

United Kingdom, 07 Nov 2025

ok

EQUITIES OF THE SAME SECTOR

Healthcare Services Group Inc

Healthcare Services Group Inc Valor: 938239

Annual Return

-50%0%+50%

Risk level

110

0.16%USD 19.35

Janux Therapeutics Inc

Janux Therapeutics Inc Valor: 111742522

Annual Return

-50%0%+50%

Risk level

110

-2.58%USD 15.46

Emeis

Emeis Valor: 132546338

Annual Return

-50%0%+50%

Risk level

110

0.15%EUR 13.73

Orion Oyj

Orion Oyj Valor: 2553367

Annual Return

-50%0%+50%

Risk level

110

-2.26%EUR 73.45

Terveystalo Oyj

Terveystalo Oyj Valor: 37893402

Annual Return

-50%0%+50%

Risk level

110

-1.41%EUR 8.37

Smith & Nephew PLC

Smith & Nephew PLC Valor: 1111046

Annual Return

-50%0%+50%

Risk level

110

-4.00%USD 32.84

Medtronic PLC

Medtronic PLC Valor: 25187155

Annual Return

-50%0%+50%

Risk level

110

-3.53%USD 82.00

Krystal Biotech Inc

Krystal Biotech Inc Valor: 38026052

Annual Return

-50%0%+50%

Risk level

110

-1.39%USD 272.66

ImmunityBio Inc

ImmunityBio Inc Valor: 110468647

Annual Return

-50%0%+50%

Risk level

110

-1.22%USD 8.10

LeMaitre Vascular inc

LeMaitre Vascular inc Valor: 2755054

Annual Return

-50%0%+50%

Risk level

110

-2.70%USD 111.90

SIX

FactSet

Clearbit

Logos provided by Clearbit